Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

BEBPA US 2020 Virtual Booth

  • May 13, 2020–Jun 30, 2020

Like you, we're sorry this live event was canceled. However, you don't have to lose out on the latest information on our functional bioassays for biologic drug discovery. Our virtual booth has all the highlights that you would have seen at the show!

Poster Presentations

Don't worry--you won't miss a thing from our posters that were due to be presented at BEBPA US 2020. Our scientists present their results in these poster videos. You can also download a PDF version to review later. 

jey-cheng-125x125

Developing a Bioluminescent PBMC ADCC Assay for the Discovery and Characterization of Therapeutic Antibodies

Presented by Jey Cheng, Sr. Research Scientist

Download PDF

jamison-grailer-125

Quantitative Cell-Based Bioassays to Advance Immunotherapy Programs Targeting Immune Checkpoint Receptors

Presented by Jamison Grailer, Sr. Research Scientist

Download PDF

New Products

Lumit™ Immunoassays

Replace conventional immunoassays, such as Western blots and ELISAs, with new Lumit™ Immunoassays. These assays offer direct luminescence measurement in cell culture, broad dynamic range, and can be completed in as little as 30 minutes.

Lumit™ Immunoassays are available for a range of applications, including protein phosphorylation and pathway analysis, FcRn binding, cytokine detection, metabolite research, and more. You can also build your own Lumit™ immunoassays with our labeling and detection kits.

Learn More

Lumit immunoassay principle

General principle of a Lumit Immunoassay. Antibodies are chemically labeled with the small and large subunits of NanoLuc® Luciferase, known as SmBiT and LgBiT, respectively. In the presence of an analyte, the two antibodies come into close proximity, allowing SmBiT and LgBiT to form an active enzyme and generate a bright luminescence signal.

Webinar

Biologics Forum: Tips and Tools for Successful Immunotherapy Bioassay Development

Mechanism of action (MOA)-based bioassays are a critical component of biologics drug development. However, establishing a functional bioassay that meets the regulatory guidelines for use in potency determination and lot release can be challenging. Join our panel of bioassay experts for a discussion on bioassay design and selection, assay optimization, and bioassay qualification for potency lot release.

This webinar was originally presented in April 2019 and is being rebroadcast by popular demand.

Date: Wednesday, April 22, 2020

Time: 11:00 am CDT (12:00 pm EDT)

Register Now

Interested in more information about functional bioassays?

View Products